This page lists the spine surgery hospitals in our directory offering Spine Tumor Surgery in Chennai, India, including Apollo Hospitals, Greams Road, Gleneagles Global Hospital, Dr. Rela Institute and Medical Centre, SIMS Hospital and others. Each listing links through to the hospital's full profile page.
Ask us about spine tumor surgery in Chennai, India
Share a few details and our care coordination team will get back to you with next steps.
Compare 8 accredited hospitals for Spine Surgery in Chennai, India
Featured🇮🇳 Apollo Hospitals, Greams Road
Ranks #1 in this list by listed rating (4.7/5 from 125 reviews).
🇮🇳 Gleneagles Global Hospital
Ranks #2 in this list by listed rating (4.7/5 from 112 reviews).
🇮🇳 Dr. Rela Institute and Medical Centre
Ranks #3 in this list by listed rating (4.7/5 from 108 reviews).
🇮🇳 SIMS Hospital
Ranks #4 in this list by listed rating (4.6/5 from 20 reviews).
🇮🇳 Sankara Nethralaya
Ranks #5 in this list by listed rating (4.4/5 from 220 reviews).
🇮🇳 Apollo First Med Hospitals, Kilpauk
Ranks #6 in this list by listed rating (4.4/5 from 76 reviews).
🇮🇳 MIOT International
Ranks #7 in this list by listed rating (4.4/5 from 200 reviews).
🇮🇳 MGM Healthcare
Ranks #8 in this list by listed rating (3.7/5 from 34 reviews).
How we selected these hospitals
A hospital appears on this page when Spine Surgery is among its listed specialties and it is located in Chennai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Spine Tumor Surgery in Chennai, India?
Choosing the right hospital for spine tumor surgery is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include spine surgery rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Spine Tumor Surgery
Spine tumor surgery encompasses a spectrum of complex neurosurgical and orthopedic oncology procedures designed to remove or control neoplasms arising from or metastasizing to the vertebral column, spinal cord, and nerve roots — conditions that, left untreated, cause irreversible paralysis, intractable pain, and neurological deterioration. With surgical success rates for en bloc resection of primary spinal tumors reaching 85–92% in high-volume centers, and functional neurological recovery reported in over 78% of patients undergoing decompression for metastatic cord compression, outcomes are strongly correlated with surgical expertise and institutional volume. GAF Healthcare connects international patients with India's and the UAE's leading academic spine oncology centers, providing end-to-end coordination across consultation, surgery, rehabilitation, and repatriation — at a fraction of Western costs and without compromise on technology or accreditation standards. Hospital Stay: 7–14 days (varies by tumor type, spinal level, and extent of reconstruction) • Total Stay in Country (Fit-to-Fly): 4–8 weeks (shorter for minimally invasive decompression; longer after multi-level corpectomy with instrumented fusion) • Success Rate: 85–92% (en bloc resection, primary tumors); 78–85% (functional neurological recovery, metastatic disease)
Clinical Overview
Spinal tumors are classified by anatomical compartment — extradural (within the bony vertebral column, most commonly metastatic), intradural-extramedullary (arising from meninges or nerve root sheaths, e.g., meningiomas and schwannomas), and intramedullary (within the spinal cord substance, e.g., ependymomas and astrocytomas). Each compartment demands a distinct surgical philosophy, anatomical approach, and neurophysiological monitoring strategy. Metastatic spinal disease — the most prevalent category — is seen in 30–70% of systemic cancer patients at autopsy, with breast, lung, prostate, renal cell carcinoma, and multiple myeloma accounting for the majority of symptomatic cases. Primary spinal tumors, while rarer, include chordoma, osteosarcoma, Ewing's sarcoma, giant cell tumor of bone, and hemangioblastoma, each requiring tumor-specific oncological staging and margin planning. The physiological impact of a spinal tumor is determined by its rate of growth, vascularity, relationship to the spinal cord and cauda equina, and the degree of vertebral structural compromise. Epidural cord compression — the most acute emergency — occurs when tumor mass reduces the spinal canal diameter by more than 25–50%, producing myelopathic signs: progressive weakness, sensory loss in a dermatome-specific or cape-like distribution, autonomic dysfunction (bladder/bowel incontinence or retention), and, in cervical disease, respiratory compromise. Spinal instability from vertebral body destruction increases fracture risk with ordinary physiological loads, causing mechanical pain distinct from the nocturnal, inflammatory pain of tumor infiltration. The Spinal Instability Neoplastic Score (SINS) — ranging from 0 to 18 — is the internationally validated tool used to triage patients toward surgical versus non-surgical management: scores of 0–6 indicate stability; 7–12 suggest potential instability warranting surgical consultation; and 13–18 mandate surgical stabilization. The contemporary standard of care for spinal tumor management is multidisciplinary and evidence-based, integrating spine oncology surgery, medical oncology, radiation oncology (including stereotactic radiosurgery), interventional neuroradiology (for preoperative embolization of hypervascular tumors), and palliative care. Surgical goals are stratified by intent: curative en bloc resection for select primary tumors (guided by the WBB — Weinstein-Boriani-Biagini — staging system for surgical margin planning), versus palliative decompression and stabilization for metastatic disease to restore or preserve neurological function and quality of life. The landmark SPORT trial and subsequent Patchell randomized controlled trial established that circumferential decompression with rigid instrumented stabilization is superior to radiation alone for metastatic cord compression in patients with a reasonable life expectancy, forming the evidentiary backbone of modern surgical decision-making.
Who is a Candidate?
• ELIGIBLE CANDIDATES: • Patients with radiographically confirmed spinal tumor causing progressive neurological deficits (myelopathy, radiculopathy, or cauda equina syndrome) regardless of tumor etiology • Patients with spinal instability confirmed by a SINS score of 7 or above, with or without neurological compromise • Primary spinal tumor patients (chordoma, giant cell tumor, osteosarcoma, Ewing's sarcoma, hemangioblastoma) where wide or marginal surgical margins are achievable based on WBB staging • Patients with solitary or oligometastatic spinal disease and controlled systemic disease, suitable for separation surgery followed by stereotactic body radiotherapy (SBRT/SRS) • Patients with intradural-extramedullary tumors (meningiomas, schwannomas, neurofibromas) where gross total resection carries acceptable neurological risk as assessed by intraoperative neurophysiological monitoring (IONM) feasibility • Patients with intramedullary tumors (ependymoma — WHO Grade II; hemangioblastoma) where a tumor-cord interface is identifiable on gadolinium-enhanced MRI, permitting safe gross total resection • Patients with acute or subacute neurological deterioration requiring emergency decompression (Frankel/ASIA Grade A–D) within a surgical window ideally under 24–48 hours of symptom onset • Patients deemed medically fit for general anesthesia with acceptable cardiopulmonary reserve (ASA Class I–III) • REQUIRED DIAGNOSTIC WORKUP: • Gadolinium-enhanced MRI of entire spine (whole-spine survey to exclude synchronous disease) with dedicated thin-slice sequences at the index level • CT scan (bone windows) of involved vertebral segment for surgical planning: assess cortical integrity, pedicle morphology, and fusion level selection • PET-CT (FDG) or bone scintigraphy for systemic staging and identification of additional metastatic sites (mandatory for metastatic and primary malignant tumors) • CT-guided needle biopsy of the spinal lesion if histological diagnosis is not established from a prior systemic tumor (avoid biopsy tracts that contaminate surgical field in en bloc resection candidates) • Digital subtraction angiography (DSA) ± preoperative tumor embolization for hypervascular tumors (renal cell carcinoma metastases, paragangliomas, hemangiomas) 24–48 hours pre-surgery • Neurophysiological baseline assessment (EMG, NCS) if preoperative radiculopathy or myelopathy is present • Echocardiography (ECHO) and pulmonary function tests (PFTs/spirometry) for patients with known cardiopulmonary disease or planned thoracotomy approach • Serum tumor markers as clinically indicated (PSA, CA-125, AFP, LDH, serum protein electrophoresis for myeloma) • Bone mineral density (DEXA scan) if osteoporosis is suspected — impacts pedicle screw pullout strength and instrumentation planning • Multidisciplinary tumor board review of all imaging and pathology prior to surgical planning • RELATIVE CONTRAINDICATIONS: • Medically unresectable systemic disease with life expectancy under 3 months (palliative radiation ± minimal stabilization preferred) • ASA Class IV–V with prohibitive perioperative cardiac or respiratory risk • Coagulopathy unresponsive to correction (INR > 1.5 uncorrected; platelet count < 50,000/µL) • Prior high-dose radiation to the operative field without adequate recovery interval (increases wound dehiscence and CSF leak risk significantly) • ASIA Grade A (complete motor and sensory loss) for more than 24–48 hours with no neurophysiological evidence of residual cord function (surgical decompression unlikely to restore function; risk-benefit reassessment required) • Widespread bony destruction at multiple contiguous levels making stable reconstruction biomechanically unfeasible
Treatment Options & Approaches
SURGICAL APPROACHES — STANDARD TO ADVANCED: 1. POSTERIOR DECOMPRESSION WITH PEDICLE SCREW INSTRUMENTATION AND FUSION (Standard Open) The most widely performed operation for metastatic thoracic and lumbar cord compression. A midline posterior incision exposes the laminae and pedicles; laminectomy decompresses the dural sac; bilateral pedicle screws spanning 2–3 levels above and below the tumor provide rigid three-column stabilization using titanium rod-and-screw constructs. Posterolateral fusion with autograft or allograft bone graft is performed. Increasingly supplemented with vertebroplasty or kyphoplasty cement augmentation of tumor-involved bodies for anterior column support. Typical operative time: 3–5 hours. 2. SEPARATION SURGERY + STEREOTACTIC BODY RADIOTHERAPY (SBRT) — Advanced Standard of Care Developed at Memorial Sloan Kettering, this paradigm-shifting approach involves a posterior circumferential decompression creating a 2–3 mm circumferential 'separation' between residual tumor and the dural sac, followed by pedicle screw stabilization. It deliberately avoids aggressive en bloc resection in metastatic patients, instead relying on high-dose SBRT (24 Gy in 1–2 fractions or 27–30 Gy in 3 fractions) delivered post-operatively to ablate the residual epidural tumor with millimetric precision. Local control rates exceed 80–90% at 1 year. This strategy is the current international standard for most radiosensitive and radio-resistant metastatic tumors (including renal cell carcinoma and melanoma). 3. EN BLOC VERTEBRECTOMY (Tomita Procedure / WBB-Guided Resection) Reserved for primary malignant spinal tumors (chordoma, osteosarcoma, Ewing's sarcoma) and select solitary metastases. The entire vertebral body, posterior elements, and surrounding soft tissue are resected as a single intact specimen, achieving wide or marginal oncological margins. A combined anterior-posterior or posterior-only approach (depending on spinal level and WBB zone) is used. The defect is reconstructed with an expandable titanium cage (e.g., Synex, Pyramesh) or carbon fiber cage packed with bone graft, secured with long-segment posterior instrumentation. For cervical spine tumors, anterior cervical corpectomy with cage and plate reconstruction is standard. This is technically the most demanding spinal oncology operation, requiring surgeons experienced in both spine surgery and surgical oncology principles. 4. MINIMALLY INVASIVE SPINE (MIS) APPROACHES • Percutaneous pedicle screw fixation: Fluoroscopy- or navigation-guided cannulated screws placed through stab incisions, dramatically reducing blood loss (estimated blood loss 200–400 mL vs. 800–1,500 mL open) and wound complications in immunocompromised or frail oncology patients. Particularly valuable in patients with poor wound healing potential (prior radiation, steroid use, malnutrition). • MIS lateral transpsoal approach (XLIF/DLIF): Allows anterior column reconstruction through a retroperitoneal flank incision without thoracotomy, reducing pulmonary morbidity in thoracolumbar junction tumors. • Endoscopic-assisted tumor resection: Thoracoscopic or posterior endoscopic approaches for anterior column tumors with reduced chest wall morbidity. • Kyphoplasty/Vertebroplasty: Fluoroscopy-guided percutaneous cement injection for painful vertebral hemangiomas or impending pathological fractures from lytic metastases when surgery is not indicated; provides immediate pain relief in 70–85% of patients. 5. INTRAMEDULLARY TUMOR RESECTION (Ependymoma, Hemangioblastoma, Astrocytoma) Requires posterior midline myelotomy — a precision incision through the dorsal midline of the spinal cord — under continuous intraoperative neurophysiological monitoring (IONM) with motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPs), and D-wave monitoring. Ultrasonic surgical aspirator (CUSA — Cavitron Ultrasonic Surgical Aspirator) and laser (CO₂ or KTP) facilitate safe dissection within cord tissue. Gross total resection is achievable in 90–95% of ependymomas given their well-demarcated pseudocapsule, but only 30–50% of astrocytomas (which are infiltrative and lack a clear plane). Intraoperative MRI (iMRI) is increasingly used in leading centers to confirm resection adequacy without repositioning the patient. 6. ROBOTICS-ASSISTED SPINE SURGERY (Mazor X Stealth, ROSA Spine, ExcelsiusGPS) Robotic platforms integrated with real-time 3D navigation provide sub-millimeter accuracy for pedicle screw trajectory planning and placement, reducing neurological injury from malpositioned screws by up to 5-fold compared to freehand techniques. Particularly critical in tumor cases where altered anatomy from vertebral destruction, prior surgery, or radiation makes landmark-based screw placement hazardous. Multiple centers in India (Fortis, Apollo, Medanta) and the UAE (Cleveland Clinic Abu Dhabi, Burjeel Medical City) have active robotic spine surgery programs. 7. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING (IONM) Mandatory for all intradural procedures and recommended for all extradural procedures involving cord-level decompression. Continuous MEP, SSEP, and EMG monitoring provides real-time feedback on cord and nerve root function, allowing the surgeon to modify the operative strategy before permanent neurological injury occurs. A ≥50% reduction in MEP amplitude or ≥10% increase in SSEP latency triggers an immediate surgical pause and corrective action protocol. 8. ADJUVANT ONCOLOGICAL THERAPIES (Integral to Surgical Planning) • SBRT/SRS: CyberKnife or Varian TrueBeam STx linear accelerators used post-separation surgery • Targeted therapy: VEGFR inhibitors (sunitinib, pazopanib) for renal cell carcinoma metastases; BRAF inhibitors (vemurafenib) for melanoma metastases — coordinated with surgical timing to minimize wound healing impairment • Immunotherapy: Checkpoint inhibitors (pembrolizumab, nivolumab) — typically held 4–6 weeks perioperatively • Bisphosphonates/Denosumab: Osteoclast inhibition for skeletal metastases and giant cell tumor of bone • Hormonal therapy: For breast and prostate cancer spinal metastases
Recovery
PRE-OPERATIVE PHASE (Weeks 1–3 Before Surgery): Step 1 — Remote Consultation and Case Review (Days 1–7): The patient submits MRI, CT, PET-CT, biopsy reports, and systemic oncology records to GAF Healthcare's spine oncology panel. A board-certified spine oncology surgeon and a multidisciplinary team conduct a virtual tumor board review. The surgical plan — approach, extent of resection, instrumentation strategy, and adjuvant treatment sequencing — is communicated to the patient with a written opinion within 48–72 hours. If tissue diagnosis is not established, CT-guided biopsy is scheduled as the first procedure upon arrival. Step 2 — Pre-Surgical Medical Clearance (Days 7–14): On arrival, the patient undergoes in-country workup: repeat MRI with surgical planning sequences, CT angiography if vessel involvement is suspected, ECHO and PFTs for patients undergoing anterior approaches, hematological optimization (correction of anemia with preoperative EPO or iron infusion if Hb < 10 g/dL, transfusion if < 8 g/dL), and nutritional assessment. Steroids (dexamethasone 8–16 mg/day in divided doses) are initiated for patients with cord edema and significant neurological compromise. Preoperative embolization of hypervascular tumors is performed 24–48 hours before surgery by interventional neuroradiology. Step 3 — Surgical Team Briefing and IONM Setup (Day of Surgery – 2 hours pre-op): Anesthesia and neurophysiological monitoring teams establish baseline MEP, SSEP, and EMG waveforms under total intravenous anesthesia (TIVA with propofol and remifentanil — mandatory for accurate IONM). Blood products (packed red cells, FFP, platelets, cryoprecipitate) are cross-matched and available. Cell-saver autotransfusion is prepared for anticipated blood loss > 500 mL. PROCEDURE (Day 0 — Operative Day): Step 4 — Surgery (Duration 3–10 hours depending on procedure): • Patient is positioned prone (posterior approach) or lateral decubitus (anterior/lateral approach) with meticulous pressure point padding and eye protection. • Intraoperative 3D navigation or robotic registration is performed after patient positioning using reference arrays or intraoperative CT (O-arm or Brainlab). • Posterior exposure, laminectomy/hemilaminectomy or transpedicular corpectomy as planned; intradural tumor: microsurgical myelotomy and tumor dissection under 4–40× magnification with CUSA. • Instrumentation: pedicle screws placed under navigation/robotic guidance; cage reconstruction of anterior column if corpectomy performed; rod-and-screw assembly torqued to specification. • Wound closure in anatomical layers with subfascial drain placed; vancomycin powder may be applied to reduce surgical site infection risk. • Intraoperative MRI performed if available for resection adequacy confirmation before wound closure. POST-OPERATIVE RECOVERY PHASE: Step 5 — Intensive Care / High-Dependency Unit (Days 1–3 post-op): Patient is monitored in ICU or HDU for neurological status (hourly motor assessments), hemodynamic stability, drain output, pain control (multimodal: IV paracetamol, dexamethasone taper, opioids via PCA pump, gabapentin for neuropathic pain), and thromboembolic prophylaxis (LMWH initiated 24–48 hours post-op; sequential compression devices intraoperatively and immediately post-op). Drain is removed when output < 30 mL/8 hours. Step 6 — Ward and Early Mobilization (Days 3–7): Spine-trained physiotherapist initiates bed mobility exercises on Day 1 post-op; supervised sitting on Day 2; standing and transfer training on Day 3 if neurologically stable. Thoracolumbosacral orthosis (TLSO brace) is fitted for lumbothoracic procedures involving corpectomy. Occupational therapist assesses activities of daily living (ADL) capacity. Wound inspection daily; sutures/staples removed at 12–14 days. Step 7 — Hospital Discharge Planning and Oncology Coordination (Days 7–14): Discharge occurs when the patient ambulates independently (with or without assistive device), pain is controlled on oral analgesics, wound is clean and healing, and SBRT/SRS planning (if separation surgery performed) has been initiated. Radiation oncology simulation CT is typically performed before discharge so SBRT can begin 2–4 weeks post-operatively (allowing wound healing without delaying radiation to residual tumor). Step 8 — Post-Discharge In-Country Rehabilitation (Weeks 2–6): Patient stays in a GAF Healthcare partner recovery apartment or rehabilitation facility near the treating hospital. Outpatient physiotherapy 5 days/week: progressive gait training, core stabilization exercises, neurological recovery exercises tailored to deficit pattern. Follow-up MRI/CT spine at 4–6 weeks to assess hardware position and early tumor response. Wound review at 2 weeks; suture removal if absorbable sutures were not used. Step 9 — Fit-to-Fly Assessment and Repatriation (Weeks 4–8): The treating surgeon conducts a formal fit-to-fly assessment. Prerequisites: wound fully healed, no active CSF leak, VTE prophylaxis established (oral anticoagulant or LMWH for flight > 4 hours), neurological status stable or improving, brace compliance confirmed, and repatriation medical summary with imaging prepared. Long-haul economy class flight is contraindicated for patients with significant residual weakness or venous thromboembolism risk — business/premium economy recommended. Medical escort arranged through GAF Healthcare if the patient's condition requires clinical supervision during repatriation.
Risks to be aware of
Spine tumor surgery carries a risk profile that is materially higher than elective spine surgery due to the altered anatomy of tumor-involved vertebrae, preoperative neurological compromise, immunosuppression from prior chemotherapy or corticosteroids, poor wound healing from prior radiation, and the physiological burden of underlying systemic malignancy. Patients and families must be counseled in detail on the following risks before consenting to surgery: NEUROLOGICAL INJURY: The most feared complication. New or worsened motor deficits (weakness or paralysis) occur in 3–8% of extradural tumor cases and 8–15% of intramedullary tumor resections, even in expert hands. Continuous IONM reduces but does not eliminate this risk. Anterior spinal artery injury during anterior column surgery can cause devastating anterior cord syndrome (loss of motor and pain/temperature sensation below the injury level with preserved proprioception). CSF LEAK AND PSEUDOMENINGOCELE: Occurs in 5–10% of intradural procedures; may require reoperation for dural repair or lumbar drain placement. Risk is amplified significantly (up to 20–30%) if the surgical field has received prior radiation therapy. SURGICAL SITE INFECTION AND WOUND DEHISCENCE: Prior radiation, corticosteroid use, malnutrition, and diabetes increase infection risk to 8–15% in irradiated patients vs. 1–3% in non-irradiated patients. Deep wound infection involving instrumentation may require implant removal, prolonged IV antibiotics, and multiple debridement surgeries. INSTRUMENTATION FAILURE: Hardware failure (rod fracture, screw pullout, cage subsidence) occurs in 3–7% of cases over 2 years, particularly in patients with osteoporotic bone, extensive vertebral destruction, or progressive systemic disease preventing bony fusion. May require revision surgery. VENOUS THROMBOEMBOLISM (DVT/PE): Oncology patients have a 4–6 fold elevated baseline VTE risk; surgery further compounds this. Deep vein thrombosis occurs in 15–30% of spinal oncology patients without prophylaxis; pulmonary embolism in 1–3%. Aggressive mechanical and pharmacological prophylaxis is mandatory. International patients must have a robust anticoagulation plan for the long-haul flight home. BLOOD LOSS AND TRANSFUSION: En bloc vertebrectomy and resection of hypervascular tumors (renal cell carcinoma, hemangioblastoma) carry estimated blood loss exceeding 2,000–4,000 mL in some cases. Preoperative embolization and cell-saver autotransfusion are essential risk-reduction strategies. Patients with hematological malignancy may have baseline coagulopathy requiring correction before surgery. ONCOLOGICAL CONSIDERATIONS: Surgery does not cure systemic metastatic disease and must be understood as a component of multimodal management. Tumor recurrence at the surgical site occurs in 10–30% of metastatic cases at 1 year without adjuvant radiation. For primary malignant tumors, the adequacy of surgical margins is the single strongest predictor of local recurrence-free survival — intralesional resection of a chordoma, for example, carries a local recurrence rate exceeding 50% at 5 years. ANESTHESIA AND MEDICAL RISKS: Prone positioning for 4–8+ hours carries risks of perioperative vision loss (ischemic optic neuropathy — rare but devastating, occurring in approximately 0.1% of prolonged prone spine cases), brachial plexus stretch injury, and pressure ulcers. Patients with significant cardiopulmonary disease require careful preoperative risk stratification using validated tools (Revised Cardiac Risk Index, RCRI).
Why GAF Healthcare
GAF Healthcare provides comprehensive end-to-end non-medical coordination, ensuring that patients and their families can focus entirely on treatment and recovery rather than administrative complexity. VISA AND TRAVEL DOCUMENTATION — INDIA: GAF Healthcare's dedicated visa team processes the Indian e-Medical Visa (e-MV) application on behalf of the patient, preparing the mandatory hospital invitation letter from the treating JCI/NABH-accredited institution, compiling supporting medical records for the visa application, and submitting through the official Indian government e-visa portal. The e-Medical Visa is typically issued within 3–5 business days and permits a stay of up to 60 days (extendable), with provisions for one accompanying attendant on an e-Medical Attendant Visa. Patients are advised to apply at least 10–14 days before the intended travel date. VISA AND TRAVEL DOCUMENTATION — UAE (DUBAI / ABU DHABI): The UAE offers visa-on-arrival for passport holders of over 50 countries (including EU, UK, US, Canada, and GCC nationals) for stays up to 30–90 days depending on nationality. For patients from other countries, GAF Healthcare coordinates a medical visitor visa or standard tourist visa through the treating hospital's international patient department, which is typically processed within 5–7 business days. DHA (Dubai Health Authority) and DOH (Abu Dhabi Department of Health) registered hospitals facilitate expedited visa processing for medical cases. AIRPORT ARRIVAL AND TRANSFERS: GAF Healthcare arranges private ambulance transfers for patients with active neurological deficits or limited mobility, and private car/SUV transfers for ambulatory patients. Transfer vehicles are confirmed 48 hours before arrival. An air freight or excess baggage coordination service is available for patients traveling with wheelchair or orthotic equipment. DEDICATED PATIENT COORDINATORS AND TRANSLATORS: Each patient is assigned a bilingual GAF Healthcare patient coordinator (available 24/7 via WhatsApp and phone) who accompanies the patient to hospital admissions, pre-operative appointments, and discharge planning meetings. Professional medical interpreters are available for Arabic, Russian, Kazakh, Uzbek, French, Swahili, and other languages, ensuring accurate informed consent and post-operative instruction comprehension. ACCOMMODATION FOR PATIENT AND ATTENDANT: GAF Healthcare maintains a curated portfolio of partner serviced apartments, recovery hotels, and rehabilitation guest houses within a 2–5 km radius of all partner hospitals in Delhi, Mumbai, Chennai, Hyderabad, Dubai, and Abu Dhabi. Accommodations are selected for accessibility (lift access, roll-in shower, grab rails) to suit post-operative spine patients. Meal arrangements, housekeeping, laundry, and pharmacy delivery are coordinated. Attendant accommodation is typically included in the all-inclusive package or available at a negotiated GAF Healthcare rate. POST-DISCHARGE AND REPATRIATION SUPPORT: GAF Healthcare coordinates follow-up telemedicine consultations with the treating surgeon at 2 weeks, 6 weeks, and 3 months post-repatriation. A comprehensive medical summary, operative report, implant card (with device serial numbers and manufacturer details for airport security purposes), imaging on encrypted USB drive, and discharge prescription are prepared in English and the patient's national language. Medical escort services for long-haul repatriation flights are available through GAF Healthcare's partner air ambulance and medical escort providers.
Common questions about Spine Tumor Surgery
What is the cost of Spine Tumor Surgery in India vs. the UAE?
How long do I need to stay in India or the UAE before I am fit to fly home after spine tumor surgery?
What is the success rate of spine tumor surgery, and what factors influence outcomes?
Related pages
How GAF Healthcare Assists in Choosing the Best Hospital for Spine Tumor Surgery in Chennai, India
Discover the Top Hospitals for Spine Tumor Surgery in Chennai, India
This page lists 8 accredited spine surgery hospitals in Chennai, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Frequently asked questions about spine tumor surgery in Chennai, India
How many spine surgery hospitals are listed in Chennai, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there spine surgery hospitals for this in other India cities?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for spine tumor surgery in Chennai, India.
Contact us to report an inaccuracy on this page.